Hepatotoxicities Induced by Neoadjuvant Chemotherapy in Colorectal Cancer Liver Metastases: Distinguishing the True From the False.
Conclusions: There is a probable association between non-alcoholic steatohepatitis (NASH) and irinotecan. Oxaliplatin seems to lead to higher vascular lesions. Except in the presence of pre-existent comorbidities, liver toxicities should not restrain the use of pre-operative chemotherapy prior to parenchymal-sparing surgery.
PMID: 30718969 [PubMed]
Source: Clinical Colorectal Cancer - Category: Cancer & Oncology Authors: Desjardin M, Bonhomme B, Le Bail B, Evrard S, Brouste V, Desolneux G, Fonck M, Bécouarn Y, Béchade D Tags: Clin Med Insights Oncol Source Type: research
More News: Alcoholism | Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Eloxatin | Liver | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Pathology | Study | Toxicology | Urology & Nephrology